NEW YORK, Sept. 5 — Israeli bioinformatics company Compugen (Nasdaq: CGEN) said on Tuesday its second quarter net loss widened to $3.9 million, or 61 cents per basic and diluted share, from $2.0 million, or 34 cents per basic and diluted share, in the year ago period.

The company said its second quarter revenues more than doubled to $1.4 million from $655,000 in second-quarter 1999.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.